biomarkers and patient eligibility for car t-cell therapies in dlbcl
Published 1 year ago • 121 plays • Length 15:50Download video MP4
Download video MP3
Similar videos
-
15:50
biomarkers and patient eligibility for car t cell therapies in dlbcl
-
17:24
biomarkers and patient eligibility for car t-cell therapies in mm
-
5:55
car t-cell therapy in dlbcl
-
10:41
car t-cell case study: sequencing therapies for patients with high-risk dlbcl
-
0:36
how successful is car-t for b-cell lymphoma?
-
2:19
car t-cell therapy in b-cell malignancies
-
1:29
what is car t cell therapy?
-
52:00
car t cell therapy for lymphoma webinar video august 2023
-
1:01:47
understanding car t cell therapy and lymphoma | lrf webinars
-
6:37
zuma-7: axi-cel in r/r large b-cell lymphoma
-
54:11
car t-cells in lymphoma: new advances and practical aspects
-
5:08
winfried f. pickl, md, on using a novel biomarker to predict car-t responses in dlbcl
-
3:01
phase 1 trial of car t-cell therapy for lymphoma
-
8:01
novel diagnostics & biomarkers for dlbcl and ctcl
-
2:31
car t-cell therapy toxicities in b-cell lymphomas
-
4:05
selecting therapy for relapsed-refractory dlbcl
-
2:55
car t-cell update: what’s new in dlbcl and mm?
-
50:26
diagnosing lymphoma with diagnostic and biomarker testing